Bartoletti, Michele
 Distribuzione geografica
Continente #
NA - Nord America 3.044
AS - Asia 2.987
SA - Sud America 708
EU - Europa 601
AF - Africa 65
OC - Oceania 9
Totale 7.414
Nazione #
US - Stati Uniti d'America 2.952
SG - Singapore 1.662
BR - Brasile 582
CN - Cina 552
VN - Vietnam 393
IT - Italia 110
IE - Irlanda 100
HK - Hong Kong 99
FI - Finlandia 90
GB - Regno Unito 46
DE - Germania 45
RU - Federazione Russa 44
IN - India 40
AR - Argentina 39
BD - Bangladesh 38
MX - Messico 36
CA - Canada 35
FR - Francia 35
IQ - Iraq 30
EC - Ecuador 28
NL - Olanda 26
JP - Giappone 24
PL - Polonia 23
ZA - Sudafrica 23
ES - Italia 20
ID - Indonesia 17
MY - Malesia 17
TR - Turchia 15
CO - Colombia 13
PE - Perù 12
PK - Pakistan 12
PY - Paraguay 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
SE - Svezia 10
EG - Egitto 9
UA - Ucraina 9
AU - Australia 8
LT - Lituania 8
PH - Filippine 8
VE - Venezuela 8
CL - Cile 7
MA - Marocco 7
IR - Iran 6
RS - Serbia 6
TN - Tunisia 6
AT - Austria 5
BH - Bahrain 5
KE - Kenya 5
KR - Corea 5
AL - Albania 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BG - Bulgaria 3
LV - Lettonia 3
PA - Panama 3
SV - El Salvador 3
TW - Taiwan 3
CR - Costa Rica 2
GY - Guiana 2
KG - Kirghizistan 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TJ - Tagikistan 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ER - Eritrea 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 7.411
Città #
Dallas 897
Singapore 679
Ashburn 519
San Jose 367
The Dalles 312
Shanghai 245
Boardman 132
Ho Chi Minh City 129
Dublin 100
Hong Kong 95
New York 93
Helsinki 90
Los Angeles 90
Beijing 79
Hanoi 78
São Paulo 56
Santa Clara 48
Milan 30
Rio de Janeiro 23
Orem 22
Da Nang 21
Moscow 20
Haiphong 19
Warsaw 19
Tokyo 18
Seattle 16
Baghdad 15
Mexico City 15
Curitiba 14
Brasília 13
Brooklyn 13
Dhaka 13
Montreal 13
Amsterdam 12
Assago 12
Johannesburg 12
Phoenix 12
Chennai 11
Council Bluffs 11
Cuenca 11
Tashkent 11
Belo Horizonte 10
Toronto 10
Boston 9
Chandler 9
Kuala Lumpur 9
Bắc Ninh 8
Cairo 8
Jeddah 8
London 8
Manchester 8
Chicago 7
Lima 7
Quito 7
San Francisco 7
Asunción 6
Frankfurt am Main 6
Genoa 6
Paris 6
Porto Alegre 6
Quảng Ngãi 6
Ribeirão Preto 6
Sorocaba 6
Stockholm 6
Vũng Tàu 6
Wilmington 6
Ankara 5
Biên Hòa 5
Go Vap 5
Guangzhou 5
Guayaquil 5
Ha Long 5
Hillsboro 5
Hải Dương 5
Manaus 5
Mauá 5
Nairobi 5
Naples 5
Queens 5
Quảng Ninh 5
Ribeirão das Neves 5
São Luís 5
Thái Nguyên 5
Addis Ababa 4
Atlanta 4
Barcelona 4
Belfast 4
Brisbane 4
Campinas 4
Campo Grande 4
Can Tho 4
Casablanca 4
Florence 4
Joinville 4
Karachi 4
Madrid 4
Manama 4
Manila 4
Medellín 4
Montevideo 4
Totale 4.719
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 426
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 376
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 105
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 96
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 86
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 83
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 82
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 76
Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey 73
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 66
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19 65
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 62
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 62
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 61
Bloodstream infections in patients with liver cirrhosis 61
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 61
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 61
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 60
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 59
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors 59
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 58
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 58
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 58
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 56
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 56
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 55
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 55
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 54
Advances in the therapy of bacterial bloodstream infections 54
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors 53
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 53
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 53
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 52
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 52
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 52
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 51
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 51
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience 50
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 50
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 50
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 50
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 49
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 49
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 49
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 49
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 48
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 48
Carbapenemase-producing Enterobacteriaceae in transplant patients 48
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 47
Opportunistic infections in end stage liver disease 47
Microbiology of periprosthetic infections following implant-based breast reconstruction surgery: a multicentric retrospective study 47
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 47
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 47
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 47
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 47
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 46
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors 46
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 46
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 46
Toscana virus infections in northern Italy: laboratory and clinical evaluation 46
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 46
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 46
ESCMID COVID-19 living guidelines: drug treatment and clinical management 45
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 45
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 45
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 45
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis 44
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 44
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 44
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 44
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy 44
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 43
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 43
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 43
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 43
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 43
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 42
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 42
COVID-19-associated pulmonary aspergillosis, March-August 2020 42
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 42
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 42
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 41
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 41
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 41
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge 40
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy 40
The Gut Microbiota of Critically Ill Patients With COVID-19 40
Risk Factors for Infection With Carbapenem-Resistant Klebsiella pneumoniae After Liver Transplantation: The Importance of Pre- and Posttransplant Colonization 40
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape 40
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 40
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 40
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 40
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 39
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 39
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 39
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 39
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 39
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 39
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 39
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 38
Totale 5.771
Categoria #
all - tutte 39.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 2 0 1
2021/20224 0 0 0 1 0 0 0 1 0 0 2 0
2022/2023134 4 0 2 3 0 3 0 2 4 2 111 3
2023/20241.043 62 70 203 37 62 171 89 52 17 50 118 112
2024/20251.567 30 8 17 39 35 202 88 96 282 465 140 165
2025/20264.819 552 615 827 395 226 252 1.206 241 244 261 0 0
Totale 7.578